Literature DB >> 3937002

Methodologies for quantifying the results of intravesical chemotherapy of superficial tumors of the bladder.

K Jauhiainen, O Alfthan.   

Abstract

Various evaluation methods exist to report results of installation therapy on superficial urinary bladder cancer. The following three, based on material previously gathered from 30 patients treated with adriamycin instillations, are analysed in this study: (1) The graphic expression method which covers the most necessary details, but demands space and does not permit adequate statistical analysis. (2) Evaluating the terms usually used in oncology, i.e. complete response (CR), partial response (PR), total response (TR), no change and progression. These are suitable for statistical analysis and are of crucial relevance in the study of carcinoma in situ TIS. In Ta-1 cancers however, these terms (CR, etc.) are not descriptive of time, and since their results depend completely on the choice of endpoints they do not permit realistic statistical analysis. (3) Determining indices (Ri/m, Ri/c) and recurrence rates (RR, MARR, MTBR) in Ta-1 cancers. These factors take into consideration both the time variable and multicentricity in space and time, making rigorous statistical analysis possible. In our opinion Ri/c states most accurately a patient's clinical course.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3937002     DOI: 10.1007/bf02934910

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  11 in total

1.  Thiotepa in the treatment of tumours of the bladder.

Authors:  H C JONES; J SWINNEY
Journal:  Lancet       Date:  1961-09-16       Impact factor: 79.321

2.  Papillomata of bladder treated with podophyllin; preliminary report.

Authors:  J E SEMPLE
Journal:  Br Med J       Date:  1948-06-26

3.  Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder.

Authors:  A Abbassian; D M Wallace
Journal:  J Urol       Date:  1966-10       Impact factor: 7.450

4.  Mitomycin C bladder instillation therapy for bladder tumors.

Authors:  T Mishina; K Oda; S Murata; H Ooe; Y Mori
Journal:  J Urol       Date:  1975-08       Impact factor: 7.450

5.  Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.

Authors:  H Huland; U Otto; M Droese; G Klöppel
Journal:  J Urol       Date:  1984-07       Impact factor: 7.450

6.  Intravesical adriamycin therapy in carcinoma in situ of the urinary bladder.

Authors:  A Ek; S Hellsten; H Henrikson; I Idwall; C E Lindholm; K Lindholm; P Mikulowski; W Månsson
Journal:  Scand J Urol Nephrol       Date:  1984

7.  Does intravesical chemotherapy prevent invasive bladder cancer?

Authors:  D F Green; M R Robinson; R Glashan; D Newling; O Dalesio; P H Smith
Journal:  J Urol       Date:  1984-01       Impact factor: 7.450

8.  Topical doxorubicin hydrochloride therapy for carcinoma in situ of the bladder: a followup.

Authors:  G Jakse; F Hofstädter; H Marberger
Journal:  J Urol       Date:  1984-01       Impact factor: 7.450

9.  Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.

Authors:  K Jauhiainen; O Alfthan
Journal:  Ann Chir Gynaecol       Date:  1984

10.  Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone.

Authors:  C C Schulman; M Robinson; L Denis; P Smith; G Viggiano; M de Pauw; O Dalesio; R Sylvester
Journal:  Eur Urol       Date:  1982       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.